Tag: clinical trial labeling errors

Sample Mislabeling: Prevention Strategies with Risk-Based Oversight

Posted on digi By digi

Sample Mislabeling: Prevention Strategies with Risk-Based Oversight Sample Mislabeling: Prevention Strategies with Risk-Based Oversight Introduction: Why Mislabeling is a Critical GCP Violation Sample mislabeling in clinical trials can result in compromised data integrity, participant risk, protocol deviations, and regulatory inspection findings. Regulatory bodies such as the FDA, EMA, and MHRA consider incorrect, incomplete, or missing…

Read More “Sample Mislabeling: Prevention Strategies with Risk-Based Oversight” »

Laboratory and Sample Management, Sample Collection SOPs

Clinical Trial Kit Assembly and Labeling in Logistics

Posted on digi By digi

Clinical Trial Kit Assembly and Labeling in Logistics Ensuring Compliance in Clinical Trial Kit Assembly and Labeling Introduction: Why Trial Kit Management is Critical Clinical trial kits are essential tools for ensuring consistent dosing, patient adherence, and blinded study design. They typically contain investigational medicinal products (IMPs), comparators, and ancillary supplies. For US-based pharma professionals,…

Read More “Clinical Trial Kit Assembly and Labeling in Logistics” »

Clinical Trial Logistics, Clinical Trial Operations & Compliance